Financing Research and Development Facilities Through Share Acquisition Rights
First written in FY2021. 4 of 5 entries say "Advanced", first in FY2022-Q1. Latest entry: FY2022.
1 other company's latest entry also says "Advanced".
- FY2022AdvancedAnnual report
「Fiscal year 43 (1 April 2021 to 31 March 2022) Number of bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., exercised during the period (units) 4,980 Number of shares delivered upon exercise during the period (shares) 547,800 Funds raised through exercises during the period (¥ thousands) 765,574」
In FY2022, 4,980 stock acquisition rights were exercised, 547,800 shares were delivered and ¥765.574 million was raised. The acquisition and cancellation of the remaining stock acquisition rights were also completed on 1 April 2022. - FY2022-Q3AdvancedAnnual report
「Number of bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., exercised during the quarter (units) 1,370 Number of shares delivered upon exercise during the quarter (shares) 150,700 Average exercise price, etc., for exercises during the quarter (¥) 1,409 Funds raised through exercises during the quarter (¥ thousands) 212,434 Cumulative number of bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., exercised as of the end of the quarter (units) 3,420 Cumulative number of shares delivered in connection with such bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., as of the end of the quarter (shares) 376,200 Cumulative average exercise price, etc., for such bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., as of the end of the quarter (¥) 1,383 Cumulative funds raised through such bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., as of the end of the quarter (¥ thousands) 520,636」
During the third quarter, 1,370 stock acquisition rights were exercised, 150,700 shares were delivered and ¥212.434 million was raised. Cumulative funds raised reached ¥520.636 million. - FY2022-Q2AdvancedAnnual report
「Number of bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., exercised during the second quarter (units) 1,230 Number of shares delivered upon exercise during the quarter (shares) 135,300 Funds raised through exercises during the quarter (¥ thousands) 188,742」
During the second quarter, 1,230 stock acquisition rights were exercised, 135,300 shares were delivered and ¥188.742 million was raised. Cumulative funds raised reached ¥308.201 million. - FY2022-Q1AdvancedAnnual report
「Number of bonds with stock acquisition rights subject to exercise-price adjustment clauses, etc., exercised during the quarter (units) 820 Number of shares delivered upon exercise during the quarter (shares) 90,200 Funds raised through exercises during the quarter (¥ thousands) 119,459」
During the first quarter, 820 stock acquisition rights were exercised, 90,200 shares were delivered and ¥119.459 million was raised. - FY2021First statedAnnual report
「The funds raised through the exercise of these stock acquisition rights will be allocated to costs related to R&D facilities.」
Issued stock acquisition rights through a third-party allotment to fund R&D facilities; the disclosure states that the rights cover 660,000 shares, may be exercised from 26 March 2021 through 31 March 2023, and would raise ¥920,073,000 at the minimum exercise price.